摘要
目的:通过观察戊酸雌二醇(商品名称为补佳乐)、安宫黄体酮序贯疗法对月经不调的疗效,探讨其对建立人工周期的作用。方法:将2003年3月-2005年2月来我院门诊的192例月经不调患者按病因不同分为青春期功血、卵巢早衰性闭经及围绝经期功血3组,采用戊酸雌二醇(补佳乐)、安宫黄体酮序贯治疗3-6个周期后,观察患者症状及用药前后血清激素水平。结果:所有病例停药后均发生少、中量撤退性出血,出血时间(5±2.5)天,青春期功血组停药后月经周期恢复正常者占56,9%;卵巢早衰组占9.3%;围绝经期功血组为20.2%,与用药前相比,各组血清激素水平有显著性变化(P〈0.05),后两组更年期症状明显改善(P〈0.05)。结论:戊酸雌二醇(补佳乐)人工周期治疗月经不调患者可使其恢复正常月经周期,调节H-P-O轴功能,同时对卵巢早衰和围绝经期的全身并发症亦有显著疗效。
Objective: To evaluate the effect of progynova and medroxyprugesterune acetate in patients with irregular menstruation. Methods: 192 patients with irregular menstruation were divided into 3 groups by etiopathogenisis, group of adolescent dysfunctional uterine bleeding, group of premature ovarian failure and group of perimenopausal. All patients received 1 mg progynova and 8 mg medroxyprogesterone acetate daily in cyclic sequential regimen. The duration of treatment was 3-6 cycles. Climacteric symptoms were scored before and after treatment. Serum FSH, LH, estradiol and progestogen level were measured at the same time. Results: Withdrawal bleeding occurred in each patient. Time of bleeding was 5±2. 5 days. After stopping cyclic sequential regimen, the recovery rate of normal menstruation cycle in group of adolescent dysfunctional uterine bleeding, group of premature ovarian failure and group of perimenopausal were 56.9% , 9. 3% and 20. 2% respectively. Serum hormone level increased significantly ( P 〈 0. 05 ) pre- and post -therapy in each group. Climacteric symptoms were relieved significantly (P 〈 0. 05 ) both in group of premature ovarian failure and group of perimenopausal. Conclusion: Progynova can adjust cycle of menstruation and relieve climacteric symptoms.
出处
《中国妇幼保健》
CAS
北大核心
2006年第12期1678-1680,共3页
Maternal and Child Health Care of China